Abstract | BACKGROUND: MATERIALS AND METHODS: In a case-control study, conducted between January 2006 and June 2010, 204 patients ≤45 years of age with ischemic stroke and 204 controls matched by age and gender, were recruited. The Glu298Asp and 4G/5G polymorphisms were determined in all participants by polymerase chain reaction-restriction fragment length polymorphism. RESULTS: There was a significant difference in the Glu298Asp genotype distribution (P=0.001) and allele frequency between the two groups (P=0.001). The 4G/5G genotype distribution (P=0.40) and the allele frequency was similar between groups; (P=0.13). There were independent factors for ischemic stroke: Asp carriage (GluAsp+AspAsp) (P=0.02); smoking (P=0.01); hypertension (P=0.03), and familial history of atherothrombotic disease (P=0.04). CONCLUSIONS: The Asp allele from the Gu298Asp gene represents an independent risk factor for ischemic stroke in a young Mexican population. In contrast, the 4G/5G was not associated with an increased risk for this disease in the same group of patients, as previously has been demonstrated in other populations.
|
Authors | Juan Carlos Esparza-García, David Santiago-Germán, María Guadalupe Valades-Mejía, Jesus Hernández-Juárez, Eberth Aguilar-Sosa, Alfredo Leaños-Miranda, Antonio Alvarado-Moreno, Abraham Majluf-Cruz, Irma Isordia-Salas |
Journal | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
(Can J Neurol Sci)
Vol. 42
Issue 5
Pg. 310-6
(Sep 2015)
ISSN: 0317-1671 [Print] England |
PMID | 26036781
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Plasminogen Activator Inhibitor 1
- Aspartic Acid
- Glutamic Acid
- Nitric Oxide Synthase Type III
|
Topics |
- Adult
- Aspartic Acid
(genetics)
- Brain Ischemia
(complications)
- Case-Control Studies
- DNA Mutational Analysis
- Female
- Gene Frequency
- Genetic Predisposition to Disease
(genetics)
- Genotype
- Glutamic Acid
(genetics)
- Humans
- Male
- Mexico
- Nitric Oxide Synthase Type III
(genetics)
- Plasminogen Activator Inhibitor 1
(genetics)
- Polymorphism, Genetic
(genetics)
- Stroke
(etiology, genetics)
|